ONT: Clinical and biopharma growth, margin gains, and AI-driven strategy fuel long-term expansion
Strong device sales and margin improvements offset regional headwinds, with clinical and biopharma segments driving growth and a strategic focus on high-value applications. Margin expansion is expected through recycling and product advancements, while AI and software offer new revenue opportunities…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.